Market research
LXG.V LexaGene Holdings Inc
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 15M
- P/E ratio
- Not available
- Analyst target
- 0.5
- Dividend yield
- 0.0%
- Beta
- 2.26
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology & Medical Research
- ISIN
- CA52886L1031
- Market cap
- 15M
- P/E ratio
- Not available
- Analyst target
- 0.5
- Dividend yield
- 0.0%
- Beta
- 2.26
About
About LexaGene Holdings Inc
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene Holdings Inc. was incorporated in 2007 and is headquartered in Beverly, Massachusetts.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the LXG.V discussion.
5 years, 5 months ago
LexaGene Holdings Inc is currently in a long term downtrend where the price is trading 17.4% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
LexaGene Holdings Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 17.8% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 79.4% to $-3M since the same quarter in the previous year.
Based on the above factors, LexaGene Holdings Inc gets an overall score of 1/5.